Outcomes of pregnancies complicated by beta-thalassemia/hemoglobin E disease

Objective: To assess the outcomes of pregnancies affected by beta-thalassemia/hemoglobin E (β-thal/HbE) disease. Methods: A retrospective cohort study was conducted with 54 women with singleton pregnancies complicated by β-thal/HbE disease only. The controls-to-cases ratio was 2:1. Results: Although...

全面介紹

Saved in:
書目詳細資料
Main Authors: Luewan S., Srisupundit K., Tongsong T.
格式: Article
語言:English
出版: 2014
在線閱讀:http://www.scopus.com/inward/record.url?eid=2-s2.0-66549125438&partnerID=40&md5=2608b51d88b36e1c57eb26ed589db05d
http://www.ncbi.nlm.nih.gov/pubmed/19084837
http://cmuir.cmu.ac.th/handle/6653943832/2882
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
id th-cmuir.6653943832-2882
record_format dspace
spelling th-cmuir.6653943832-28822014-08-30T02:25:30Z Outcomes of pregnancies complicated by beta-thalassemia/hemoglobin E disease Luewan S. Srisupundit K. Tongsong T. Objective: To assess the outcomes of pregnancies affected by beta-thalassemia/hemoglobin E (β-thal/HbE) disease. Methods: A retrospective cohort study was conducted with 54 women with singleton pregnancies complicated by β-thal/HbE disease only. The controls-to-cases ratio was 2:1. Results: Although maternal outcomes were similar in both groups, gestational age at birth and birth weight were significantly lower in the study group and the cesarean delivery rate was significantly higher in that group (relative risk [RR], 2.1). The incidences of fetal growth restriction, preterm birth, and low birth weight were also significantly higher in the study group, with RRs of 2.8, 2.7, and 5.6, respectively. Conclusion: Pregnancies affected by β-thal/HbE disease were significantly associated with an increased risk of fetal growth restriction, preterm birth, and low birth weight. © 2008 Elsevier Ireland Ltd. All rights reserved. 2014-08-30T02:25:30Z 2014-08-30T02:25:30Z 2009 Article 00207292 10.1016/j.ijgo.2008.10.012 19084837 IJGOA http://www.scopus.com/inward/record.url?eid=2-s2.0-66549125438&partnerID=40&md5=2608b51d88b36e1c57eb26ed589db05d http://www.ncbi.nlm.nih.gov/pubmed/19084837 http://cmuir.cmu.ac.th/handle/6653943832/2882 English
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
language English
description Objective: To assess the outcomes of pregnancies affected by beta-thalassemia/hemoglobin E (β-thal/HbE) disease. Methods: A retrospective cohort study was conducted with 54 women with singleton pregnancies complicated by β-thal/HbE disease only. The controls-to-cases ratio was 2:1. Results: Although maternal outcomes were similar in both groups, gestational age at birth and birth weight were significantly lower in the study group and the cesarean delivery rate was significantly higher in that group (relative risk [RR], 2.1). The incidences of fetal growth restriction, preterm birth, and low birth weight were also significantly higher in the study group, with RRs of 2.8, 2.7, and 5.6, respectively. Conclusion: Pregnancies affected by β-thal/HbE disease were significantly associated with an increased risk of fetal growth restriction, preterm birth, and low birth weight. © 2008 Elsevier Ireland Ltd. All rights reserved.
format Article
author Luewan S.
Srisupundit K.
Tongsong T.
spellingShingle Luewan S.
Srisupundit K.
Tongsong T.
Outcomes of pregnancies complicated by beta-thalassemia/hemoglobin E disease
author_facet Luewan S.
Srisupundit K.
Tongsong T.
author_sort Luewan S.
title Outcomes of pregnancies complicated by beta-thalassemia/hemoglobin E disease
title_short Outcomes of pregnancies complicated by beta-thalassemia/hemoglobin E disease
title_full Outcomes of pregnancies complicated by beta-thalassemia/hemoglobin E disease
title_fullStr Outcomes of pregnancies complicated by beta-thalassemia/hemoglobin E disease
title_full_unstemmed Outcomes of pregnancies complicated by beta-thalassemia/hemoglobin E disease
title_sort outcomes of pregnancies complicated by beta-thalassemia/hemoglobin e disease
publishDate 2014
url http://www.scopus.com/inward/record.url?eid=2-s2.0-66549125438&partnerID=40&md5=2608b51d88b36e1c57eb26ed589db05d
http://www.ncbi.nlm.nih.gov/pubmed/19084837
http://cmuir.cmu.ac.th/handle/6653943832/2882
_version_ 1681419943142227968